The Company was founded by Michael G. Curley, Ph.D., FHRS, and Patrick S. Hamilton, Ph.D. who met at the M.I.T. Hyperthermia Center as graduate students.  


The Company was reorganized in Delaware as Thermedical in 2008.  In 2012, the Thermedical® Ablation System and the Ablation Needle received initial U.S. Food & Drug Administration (FDA) clearance for the coagulation and ablation of soft tissue during percutaneous, laparoscopic, and intraoperative surgical procedures.  This clearance was based on substantial preclinical testing carried out under multiple Small Business Innovation Research (SBIR) Grants from the National Institutes of Health (NIH) and on a matching grant from the Massachusetts Life Sciences Center.

The Thermedical® Ablation System is 510(k) cleared for the coagulation and ablation of soft tissue during percutaneous, laparoscopic and intraoperative surgical procedures.  Use of the Thermedical Ablation System for any specific soft tissue indication has not been evaluated or approved by the US FDA.

Use of the Thermedical Ablation System for the treatment of VT is investigational and is not approved for use or sale in any market.

150 Bear Hill Road,  Waltham, MA 02451-1036

©Copyright Thermedical, Inc. 2011-2015. All Rights Reserved. | Copyright and Trademark Notice 
Thermedical® and Durablate™ are trademarks of Thermedical, Inc. registered in the United States and Internationally.